Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Internet privacy

Executive Summary

Federal Trade Commission recommends that Congress enact legislation that "would set forth a basic level of privacy protection for consumer-oriented commercial websites" in a May 22 report. Legislation should require sites to provide "clear and conspicuous notice" of their information collection practices, to offer consumers choices as to how their personal identifying information is used, to offer consumers "reasonable access" to the information a site has collected about them and to take "reasonable steps" to protect the security of the information. The commission based its recommendation on a survey of commercial sites' information practices, which found only 20% of 335 sites sampled randomly implement all four information practice principles and that 42% of the 91 "most popular" groups of sites do. Among the randomly selected sites were several that offer online prescription filling, including, and

You may also be interested in...

SmithKline Avandia Recommended Only For Combination Use By CPMP

SmithKline Beecham's thiazolidinedione antidiabetic Avandia is in the final stages of EU approval following a positive recommendation by the Committee for Proprietary Medicinal Products March 16.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts